tiprankstipranks
Trending News
More News >
Optinose (OPTN)
:OPTN
US Market
Advertisement

Optinose (OPTN) Price & Analysis

Compare
Followers

OPTN Stock Chart & Stats


Optinose News

OPTN FAQ

What was Optinose’s price range in the past 12 months?
Currently, no data Available
What is Optinose’s market cap?
Currently, no data Available
When is Optinose’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Optinose’s earnings last quarter?
Currently, no data Available
Is Optinose overvalued?
According to Wall Street analysts Optinose’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Optinose pay dividends?
    Optinose does not currently pay dividends.
    What is Optinose’s EPS estimate?
    Optinose’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Optinose have?
    Currently, no data Available
    What happened to Optinose’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Optinose?
    Currently, no hedge funds are holding shares in OPTN

    Company Description

    Optinose

    Optinose (OPTN) is a specialty pharmaceutical company focused on developing and commercializing innovative products for patients treated by ear, nose, and throat (ENT) and allergy specialists. The company's core product, XHANCE, is a nasal spray designed to treat chronic rhinosinusitis with nasal polyps in adults. Optinose operates primarily within the healthcare and pharmaceutical sectors, leveraging its proprietary Exhalation Delivery System to provide effective treatments for ENT conditions.

    Optinose (OPTN) Earnings & Revenues

    Currently, no data available
    Please return soon. This page is being updated.
    Similar Stocks
    Company
    Price & Change
    Follow
    Galectin Therapeutics
    Black Diamond Therapeutics
    Vor Biopharma

    Ownership Overview

    0.36%99.64%
    Insiders
    0.36%
    Mutual Funds
    ― Other Institutional Investors
    99.64% Public Companies and
    Individual Investors

    Options Prices

    Currently, No data available
    ---
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis